Group items tagged

Many medical laboratories within the province of Ontario are operating with outdated equipment, which is a contributing factor of the incapability to dea with major outbreaks of diseases. There is a modern laboratory estimated at $ 40 million that is planned to go into MaRS Phase II complex. 

Mount Sinai Services (MSS) provides an extensive set of custom laboratory research services for researchers, pharmaceutical companies and other industry partners.

Mount Sinai Services (MSS) provides an extensive set of custom laboratory research services for researchers, pharmaceutical companies and other industry partners

Diamond Schmitt Architects will provide architectural design services for a new public health laboratory, along with office and support space, at the MaRS Centre in the Phase II development in Toronto.

"Diamond Schmitt Architects will design research laboratory space for the Ontario Institute for Cancer Research (OICR) at the MaRS Phase II west tower currently under construction in downtown Toronto." MaRS Phase II occupancy is slatted for 2013.

MaRS Discovery District has selected Alexandria Real Estate Equities Inc, the largest publicly traded U.S. life science realty company, to develop a 900,000 square foot high-rise office and laboratory complex that will include an of the atrium in the MaRS building. Jun 27, 2007

MaRS Discovery District has selected Alexandria Real Estate Equities Inc, the largest publicly traded U.S. life science realty company, to develop a 900,000 square foot high-rise office and laboratory complex that will include an of the atrium in the MaRS building.

CML HealthCare Inc is planning to automate it's current infrastructure to deliver greater volume and medical laboratory tests. CML is also working to commercialize early-stage technologies in medical diagnostics in partnership with an Ontario government agency known as MaRS Innovation.

The Star states "TowerLabs is a company that focuses on relationship making and is a project manager that helps in getting the technology installed and measures its performance in both real-world and test scenarios. It plans to test its technologies at the tower being built as part of the expansion at MaRS."

On May 17 & 18 the 2010 Annual International Conference on Research Facilities will be held in Toronto. The major issues on the agenda include getting more research results per square foot of space, lowering the costs of building and renovating research facilities, reducing facility operating costs, facilitating the new collaborative multi-disciplinary research models, planning facilities help to promote commercial technology spin-offs, and designing energy-efficient and sustainable laboratories.An important feature of the conference is the opportunity for participants to tour a number of prominent Toronto research facilities including MaRS Discovery District.

An international study based at the University of Pittsburgh has identified a human enzyme that can biodegrade carbon nanotubes. Laboratory tests showed that it could also offset the potentially damaging health effects of being exposed to such nanotechnology.

Saul Kaplan co-founder of the Business Innovation Factory sees enormous promise in Toronto's downtown core "Discovery District" for innovation (i.e. MaRS Centre).

CML HealthCare Inc is planning to automate it's current infrastructure to deliver greater volume and medical laboratory tests. CML is also working to commercialize early-stage technologies in medical diagnostics in partnership with an Ontario government agency known as MaRS Innovation.

Ten people and businesses have been selected as the 2010 winners of Ontario's Premier's Innovation Awards. For the Summit Awards, the sponsoring institutions for the winners include MaRS Discovery District, The Hospital for Sick Children, and The Samuel Lunenfeld Research Institute of Mount Sinai Hospital.

Ontario's provincial government celebrated top scientific achievements at the 2009 Premier's Innovation Awards. Mention of MaRS being the awards are co-sponsor.